Action
EGFR/MET
Approval Jurisdiction
2021 FDA
Approved for clinical use
NSCLC
CAS
2171511-58-1
Commercial Vendor
Janssen
Compound Image
Amivantamab.png
Compound name
Amivantamab
Reference
Reference 2
Approved Drug List
1